Cargando…

The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial

Weight loss (WL) differences between isocaloric high-carbohydrate and high-fat diets are generally small; however, individual WL varies within diet groups. Genotype patterns may modify diet effects, with carbohydrate-responsive genotypes losing more weight on high-carbohydrate diets (and vice versa...

Descripción completa

Detalles Bibliográficos
Autores principales: Höchsmann, Christoph, Yang, Shengping, Ordovás, José M., Dorling, James L., Champagne, Catherine M., Apolzan, John W., Greenway, Frank L., Cardel, Michelle I., Foster, Gary D., Martin, Corby K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562431/
https://www.ncbi.nlm.nih.gov/pubmed/37813841
http://dx.doi.org/10.1038/s41467-023-41969-1
_version_ 1785118126972600320
author Höchsmann, Christoph
Yang, Shengping
Ordovás, José M.
Dorling, James L.
Champagne, Catherine M.
Apolzan, John W.
Greenway, Frank L.
Cardel, Michelle I.
Foster, Gary D.
Martin, Corby K.
author_facet Höchsmann, Christoph
Yang, Shengping
Ordovás, José M.
Dorling, James L.
Champagne, Catherine M.
Apolzan, John W.
Greenway, Frank L.
Cardel, Michelle I.
Foster, Gary D.
Martin, Corby K.
author_sort Höchsmann, Christoph
collection PubMed
description Weight loss (WL) differences between isocaloric high-carbohydrate and high-fat diets are generally small; however, individual WL varies within diet groups. Genotype patterns may modify diet effects, with carbohydrate-responsive genotypes losing more weight on high-carbohydrate diets (and vice versa for fat-responsive genotypes). We investigated whether 12-week WL (kg, primary outcome) differs between genotype-concordant and genotype-discordant diets. In this 12-week single-center WL trial, 145 participants with overweight/obesity were identified a priori as fat-responders or carbohydrate-responders based on their combined genotypes at ten genetic variants and randomized to a high-fat (n = 73) or high-carbohydrate diet (n = 72), yielding 4 groups: (1) fat-responders receiving high-fat diet, (2) fat-responders receiving high-carbohydrate diet, (3) carbohydrate-responders receiving high-fat diet, (4) carbohydrate-responders receiving high-carbohydrate diet. Dietitians delivered the WL intervention via 12 weekly diet-specific small group sessions. Outcome assessors were blind to diet assignment and genotype patterns. We included 122 participants (54.4 [SD:13.2] years, BMI 34.9 [SD:5.1] kg/m(2), 84% women) in the analyses. Twelve-week WL did not differ between the genotype-concordant (−5.3 kg [SD:1.0]) and genotype-discordant diets (−4.8 kg [SD:1.1]; adjusted difference: −0.6 kg [95% CI: −2.1,0.9], p = 0.50). With the current ability to genotype participants as fat- or carbohydrate-responders, evidence does not support greater WL on genotype-concordant diets. ClinicalTrials identifier: NCT04145466.
format Online
Article
Text
id pubmed-10562431
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-105624312023-10-11 The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial Höchsmann, Christoph Yang, Shengping Ordovás, José M. Dorling, James L. Champagne, Catherine M. Apolzan, John W. Greenway, Frank L. Cardel, Michelle I. Foster, Gary D. Martin, Corby K. Nat Commun Article Weight loss (WL) differences between isocaloric high-carbohydrate and high-fat diets are generally small; however, individual WL varies within diet groups. Genotype patterns may modify diet effects, with carbohydrate-responsive genotypes losing more weight on high-carbohydrate diets (and vice versa for fat-responsive genotypes). We investigated whether 12-week WL (kg, primary outcome) differs between genotype-concordant and genotype-discordant diets. In this 12-week single-center WL trial, 145 participants with overweight/obesity were identified a priori as fat-responders or carbohydrate-responders based on their combined genotypes at ten genetic variants and randomized to a high-fat (n = 73) or high-carbohydrate diet (n = 72), yielding 4 groups: (1) fat-responders receiving high-fat diet, (2) fat-responders receiving high-carbohydrate diet, (3) carbohydrate-responders receiving high-fat diet, (4) carbohydrate-responders receiving high-carbohydrate diet. Dietitians delivered the WL intervention via 12 weekly diet-specific small group sessions. Outcome assessors were blind to diet assignment and genotype patterns. We included 122 participants (54.4 [SD:13.2] years, BMI 34.9 [SD:5.1] kg/m(2), 84% women) in the analyses. Twelve-week WL did not differ between the genotype-concordant (−5.3 kg [SD:1.0]) and genotype-discordant diets (−4.8 kg [SD:1.1]; adjusted difference: −0.6 kg [95% CI: −2.1,0.9], p = 0.50). With the current ability to genotype participants as fat- or carbohydrate-responders, evidence does not support greater WL on genotype-concordant diets. ClinicalTrials identifier: NCT04145466. Nature Publishing Group UK 2023-10-09 /pmc/articles/PMC10562431/ /pubmed/37813841 http://dx.doi.org/10.1038/s41467-023-41969-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Höchsmann, Christoph
Yang, Shengping
Ordovás, José M.
Dorling, James L.
Champagne, Catherine M.
Apolzan, John W.
Greenway, Frank L.
Cardel, Michelle I.
Foster, Gary D.
Martin, Corby K.
The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial
title The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial
title_full The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial
title_fullStr The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial
title_full_unstemmed The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial
title_short The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial
title_sort personalized nutrition study (points): evaluation of a genetically informed weight loss approach, a randomized clinical trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562431/
https://www.ncbi.nlm.nih.gov/pubmed/37813841
http://dx.doi.org/10.1038/s41467-023-41969-1
work_keys_str_mv AT hochsmannchristoph thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT yangshengping thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT ordovasjosem thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT dorlingjamesl thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT champagnecatherinem thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT apolzanjohnw thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT greenwayfrankl thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT cardelmichellei thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT fostergaryd thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT martincorbyk thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT hochsmannchristoph personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT yangshengping personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT ordovasjosem personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT dorlingjamesl personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT champagnecatherinem personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT apolzanjohnw personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT greenwayfrankl personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT cardelmichellei personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT fostergaryd personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial
AT martincorbyk personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial